MEDP - Medpace Holdings Inc
IEX Last Trade
355.29
-10.650 -2.998%
Share volume: 655,768
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$365.94
-10.65
-2.91%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-25 | 2023-02-14 | 2023-04-25 | 2023-07-25 | 2023-10-24 | 2024-02-13 | 2024-04-23 | 2024-07-23 | |
| Assets | |||||||||
| Total Assets | 1.328 B | 1.352 B | 1.396 B | 1.407 B | 1.487 B | 1.657 B | 1.796 B | 1.920 B | |
| Current Assets | 337.741 M | 333.962 M | 367.622 M | 378.927 M | 448.881 M | 593.828 M | 744.902 M | 872.523 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 57.648 M | 52.293 M | 62.954 M | 64.731 M | 60.901 M | 49.979 M | 58.726 M | 60.521 M | |
| Short Term Investments | 57.648 M | 52.293 M | 62.954 M | 64.731 M | 60.901 M | 49.979 M | 58.726 M | 60.521 M | |
| Total Receivables | 249.086 M | 253.404 M | 257.746 M | 275.058 M | 292.773 M | 298.400 M | 279.166 M | 301.108 M | |
| Current Cash | 31.007 M | 28.265 M | 46.922 M | 39.138 M | 95.207 M | 245.449 M | 407.010 M | 510.894 M | |
| Total Non-current Assets | 990.684 M | 1.019 B | 1.028 B | 1.028 B | 1.038 B | 1.063 B | 1.051 B | 1.048 B | |
| Property Plant Equipment | 104.719 M | 109.849 M | 113.755 M | 114.817 M | 114.764 M | 120.589 M | 118.600 M | 122.394 M | |
| Other Assets | 18.629 M | 21.129 M | 22.026 M | 22.261 M | 20.831 M | 24.970 M | 20.409 M | 18.451 M | |
| Intangible Assets | 38.846 M | 38.008 M | 37.458 M | 36.908 M | 36.359 M | 35.809 M | 35.448 M | 35.087 M | |
| Goodwill | 662.396 M | 662.396 M | 662.396 M | 662.396 M | 662.396 M | 662.396 M | 662.396 M | 662.396 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.328 B | 1.352 B | 1.396 B | 1.407 B | 1.487 B | 1.657 B | 1.796 B | 1.920 B | |
| Total liabilities | 978.540 M | 966.108 M | 1.048 B | 1.016 B | 1.016 B | 1.098 B | 1.124 B | 1.156 B | |
| Total current liabilities | 820.868 M | 803.470 M | 881.889 M | 852.437 M | 848.518 M | 925.131 M | 956.645 M | 993.088 M | |
| Accounts Payable | 28.245 M | 33.069 M | 37.110 M | 33.608 M | 29.023 M | 31.869 M | 24.402 M | 27.388 M | |
| Other liabilities | 17.558 M | 22.701 M | 22.793 M | 22.953 M | 23.124 M | 28.221 M | 29.082 M | 29.271 M | |
| Current long term debt | 139.700 M | 50.000 M | 115.000 M | 55.000 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 17.558 M | 22.701 M | 22.793 M | 22.953 M | 23.124 M | 28.221 M | 29.082 M | 29.271 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 349.885 M | 386.387 M | 347.262 M | 391.060 M | 470.912 M | 558.950 M | 671.542 M | 763.599 M | |
| Common stock | 31.009 M | 31.132 M | 31.008 M | 30.537 M | 30.629 M | 30.714 M | 30.843 M | 30.990 M | |
| Retained earnings | -380.115 M | -359.827 M | -408.099 M | -371.022 M | -300.197 M | -221.645 M | -119.141 M | -30.790 M |